Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria

Adjunctive transferrin to reduce the emergence of antibiotic resistance in Gram-negative bacteria
复制标题

DOI:
10.1093/jac/dkz225
复制
发表时间:
2019-09-01
影响因子:
5.2
通讯作者:
Spellberg, Brad
Spellberg, Brad
中科院分区:
医学2区
文献类型:
--
作者:
Luna, Brian M.;Ershova, Ksenia;Spellberg, Brad

文献摘要

被引文献

相似文献

背景:需要新的策略来减缓细菌病原体中抗生素耐药性的出现。特别是,社会正在经历由革兰氏阴性细菌病原体引起的耐药性感染的危机,迫切需要新的治疗方法来对抗这些疾病。从宿主获得铁几乎是微生物病原体(包括革兰氏阴性菌)引起感染的普遍需要。我们以前曾报道,脱辅基转铁蛋白,目的:明确脱铁转铁蛋白在体外抑制肺炎克雷伯菌和鲍曼不动杆菌(革兰氏阴性菌)生长,减少抗生素耐药性的产生的潜力。方法:研究了脱辅基转铁蛋白单独或与美罗培南、环丙沙星联合应用对克雷伯氏杆菌的疗效。肺炎链球菌和A.结果:证明脱铁转铁蛋白对两种致病菌的MIC均为可检测的。脱铁转铁蛋白介导的添加剂的抗菌作用,这两种抗生素对多个菌株的时间杀灭试验。最后,加入脱辅基转铁蛋白,环丙沙星或美罗培南减少了耐药突变体的出现,在20天的连续传代的两个species.Conclusions:这些结果表明,脱辅基转铁蛋白可能有希望抑制耐药突变体的出现时,治疗革兰氏阴性菌引起的感染。
Background: New strategies are needed to slow the emergence of antibiotic resistance among bacterial pathogens. In particular, society is experiencing a crisis of antibiotic-resistant infections caused by Gramnegative bacterial pathogens and novel therapeutics are desperately needed to combat such diseases. Acquisition of iron from the host is a nearly universal requirement for microbial pathogens-including Gramnegative bacteria-to cause infection. We have previously reported that apo-transferrin (lacking iron) can inhibit the growth of Staphylococcus aureus in culture and diminish emergence of resistance to rifampicin.Objectives: To define the potential of apo-transferrin to inhibit in vitro growth of Klebsiella pneumoniae and Acinetobacter baumannii, key Gram-negative pathogens, and to reduce emergence of resistance to antibiotics.Methods: The efficacy of apo-transferrin alone or in combination with meropenem or ciprofloxacin against K. pneumoniae and A. baumannii clinical isolates was tested by MIC assay, time-kill assay and assays for the selection of resistant mutants.Results: We confirmed that apo-transferrin had detectable MICs for all strains tested of both pathogens. Apotransferrin mediated an additive antimicrobial effect for both antibiotics against multiple strains in time-kill assays. Finally, adding apo-transferrin to ciprofloxacin or meropenem reduced the emergence of resistant mutants during 20 day serial passaging of both species.Conclusions: These results suggest that apo-transferrin may have promise to suppress the emergence of antibiotic-resistant mutants when treating infections caused by Gram-negative bacteria.